<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:a4dfa2b8-5e07-42ff-a28e-951ed604300f,g:33d1fd73-103d-48ee-b842-31762764c390-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.flex-pharma.com/role/COVERPAGE" xlink:type="simple" xlink:href="flks-20201231.xsd#COVERPAGE"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/COVERPAGE" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="flks-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_28c0d854-0e36-4199-a8fb-8221a741415e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_6bdca016-2158-4b3c-8ccd-a9ff0726652e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_28c0d854-0e36-4199-a8fb-8221a741415e" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_6bdca016-2158-4b3c-8ccd-a9ff0726652e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_ab46a3a5-1641-4273-aca4-0d4eb83c24e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_28c0d854-0e36-4199-a8fb-8221a741415e" xlink:to="loc_us-gaap_AccountsPayableCurrent_ab46a3a5-1641-4273-aca4-0d4eb83c24e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_flks_AccruedExpensesAndOtherCurrentLiabilities_c786c73d-804c-41fd-9aec-c1749d69c556" xlink:href="flks-20201231.xsd#flks_AccruedExpensesAndOtherCurrentLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_28c0d854-0e36-4199-a8fb-8221a741415e" xlink:to="loc_flks_AccruedExpensesAndOtherCurrentLiabilities_c786c73d-804c-41fd-9aec-c1749d69c556" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_6fdfc7a9-dcdd-4e26-9e1d-8c801e41b22f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_28c0d854-0e36-4199-a8fb-8221a741415e" xlink:to="loc_us-gaap_NotesPayableCurrent_6fdfc7a9-dcdd-4e26-9e1d-8c801e41b22f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_39faea6c-982c-45fa-b7a4-670a0af247df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_28c0d854-0e36-4199-a8fb-8221a741415e" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_39faea6c-982c-45fa-b7a4-670a0af247df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2db60682-bdfb-4357-b8bb-7223dccf4e78" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a7c50c72-70fb-469e-a046-bd1dfde62a22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2db60682-bdfb-4357-b8bb-7223dccf4e78" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a7c50c72-70fb-469e-a046-bd1dfde62a22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4c9bd589-28d3-4066-a461-e9cf47e4c381" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2db60682-bdfb-4357-b8bb-7223dccf4e78" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4c9bd589-28d3-4066-a461-e9cf47e4c381" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesNetCurrent_38746a97-acea-4976-a56b-e45928166ccd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_2db60682-bdfb-4357-b8bb-7223dccf4e78" xlink:to="loc_us-gaap_ReceivablesNetCurrent_38746a97-acea-4976-a56b-e45928166ccd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_7665e837-efd5-4a61-8b82-76a67b7bf215" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b73df977-fc69-455a-87b3-d11a2c80d5dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7665e837-efd5-4a61-8b82-76a67b7bf215" xlink:to="loc_us-gaap_StockholdersEquity_b73df977-fc69-455a-87b3-d11a2c80d5dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ca16f900-fc1c-4543-b898-b090518bfa85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_7665e837-efd5-4a61-8b82-76a67b7bf215" xlink:to="loc_us-gaap_Liabilities_ca16f900-fc1c-4543-b898-b090518bfa85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_94eac073-fd48-4be5-9cfa-7013bed9f235" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a241dee9-ca9f-41fd-a47b-b4e0554c1dbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94eac073-fd48-4be5-9cfa-7013bed9f235" xlink:to="loc_us-gaap_AssetsCurrent_a241dee9-ca9f-41fd-a47b-b4e0554c1dbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d61d0026-0a48-49e1-a6b6-1cbc728f0869" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94eac073-fd48-4be5-9cfa-7013bed9f235" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d61d0026-0a48-49e1-a6b6-1cbc728f0869" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ff63e056-33ac-41b5-9fac-3de2174c81b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94eac073-fd48-4be5-9cfa-7013bed9f235" xlink:to="loc_us-gaap_Goodwill_ff63e056-33ac-41b5-9fac-3de2174c81b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8d568100-a07c-4322-b32a-f58770e5ae4f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94eac073-fd48-4be5-9cfa-7013bed9f235" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8d568100-a07c-4322-b32a-f58770e5ae4f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1941f719-11d4-44ed-b3bc-5279fc128ab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_55f38cdc-8d6f-4908-af79-3c1e4a94d9f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1941f719-11d4-44ed-b3bc-5279fc128ab2" xlink:to="loc_us-gaap_PreferredStockValue_55f38cdc-8d6f-4908-af79-3c1e4a94d9f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_fc04367a-3649-493a-9642-5aed72e03259" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1941f719-11d4-44ed-b3bc-5279fc128ab2" xlink:to="loc_us-gaap_CommonStockValue_fc04367a-3649-493a-9642-5aed72e03259" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_848b51cb-145a-4e0e-9c8a-c2202112237d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1941f719-11d4-44ed-b3bc-5279fc128ab2" xlink:to="loc_us-gaap_AdditionalPaidInCapital_848b51cb-145a-4e0e-9c8a-c2202112237d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_453f8980-b89c-4264-a171-e249c6096fff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_1941f719-11d4-44ed-b3bc-5279fc128ab2" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_453f8980-b89c-4264-a171-e249c6096fff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="flks-20201231.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="flks-20201231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_11059d56-b9a2-43b9-9d99-cffed03375e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e18ff258-8121-4089-8159-5c9173382942" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_11059d56-b9a2-43b9-9d99-cffed03375e5" xlink:to="loc_us-gaap_OperatingExpenses_e18ff258-8121-4089-8159-5c9173382942" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1ff5cbea-6b0d-4da0-9b5a-0c4cd7a4864a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_11059d56-b9a2-43b9-9d99-cffed03375e5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_1ff5cbea-6b0d-4da0-9b5a-0c4cd7a4864a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_681c6a1b-82fa-4b67-8d6e-43c1c4bb4934" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c788249c-00ca-4ef9-a3b2-b7f1ac49f7c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_681c6a1b-82fa-4b67-8d6e-43c1c4bb4934" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c788249c-00ca-4ef9-a3b2-b7f1ac49f7c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_1fb5d094-1ddd-4f66-b967-5fbdf74b8a88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_681c6a1b-82fa-4b67-8d6e-43c1c4bb4934" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_1fb5d094-1ddd-4f66-b967-5fbdf74b8a88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_25b62742-d642-454d-8bea-5763f425a24a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount_af2baf48-9726-4a2e-b9cd-d8504c3b06d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_25b62742-d642-454d-8bea-5763f425a24a" xlink:to="loc_us-gaap_WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount_af2baf48-9726-4a2e-b9cd-d8504c3b06d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4ea9e5ef-deb4-4ffb-aa27-aab981df27ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_25b62742-d642-454d-8bea-5763f425a24a" xlink:to="loc_us-gaap_NetIncomeLoss_4ea9e5ef-deb4-4ffb-aa27-aab981df27ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_9a74ce16-09f8-4fe3-88db-62a81a18daba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_fa8f9dc2-81a1-4e4c-8d73-d9499176cc87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_9a74ce16-09f8-4fe3-88db-62a81a18daba" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_fa8f9dc2-81a1-4e4c-8d73-d9499176cc87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncome_f7979834-2df6-4abf-a494-1d0a879804b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncome"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_9a74ce16-09f8-4fe3-88db-62a81a18daba" xlink:to="loc_us-gaap_OtherNonoperatingIncome_f7979834-2df6-4abf-a494-1d0a879804b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_82c5c0ef-4f6f-42a8-bfb0-d3c017acb35a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_9a74ce16-09f8-4fe3-88db-62a81a18daba" xlink:to="loc_us-gaap_OperatingIncomeLoss_82c5c0ef-4f6f-42a8-bfb0-d3c017acb35a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_6e9ac323-c90e-463f-b96b-d115b6546ea3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperations_9a74ce16-09f8-4fe3-88db-62a81a18daba" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_6e9ac323-c90e-463f-b96b-d115b6546ea3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_43219f58-ced6-4492-9095-b2a067891c79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperations_904fe9d6-165a-46d2-9c3c-20ae91095ae8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_43219f58-ced6-4492-9095-b2a067891c79" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperations_904fe9d6-165a-46d2-9c3c-20ae91095ae8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_73059408-59c3-404b-90ed-c24c2609641d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_5359b283-0275-4231-930e-ac3c149df948" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDiluted_73059408-59c3-404b-90ed-c24c2609641d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicAndDilutedShare_5359b283-0275-4231-930e-ac3c149df948" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="flks-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8e03cd62-e485-472b-934f-f233b6da3f84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_54dcc801-b761-4066-8aa3-34696be63bb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8e03cd62-e485-472b-934f-f233b6da3f84" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_54dcc801-b761-4066-8aa3-34696be63bb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_ba59a4c4-0f19-4ca6-982f-8d711d927f3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8e03cd62-e485-472b-934f-f233b6da3f84" xlink:to="loc_us-gaap_PaymentsOfDividends_ba59a4c4-0f19-4ca6-982f-8d711d927f3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromOtherEquity_9bb750a4-03db-421a-9e95-42326b9162b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromOtherEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8e03cd62-e485-472b-934f-f233b6da3f84" xlink:to="loc_us-gaap_ProceedsFromOtherEquity_9bb750a4-03db-421a-9e95-42326b9162b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_6adeab23-ef14-43b1-8b90-c10c844ab2a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8e03cd62-e485-472b-934f-f233b6da3f84" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_6adeab23-ef14-43b1-8b90-c10c844ab2a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c99018e3-0a67-4b6c-8404-d59adf9a8348" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_ca17775b-ab6f-4d68-935f-593a662867cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c99018e3-0a67-4b6c-8404-d59adf9a8348" xlink:to="loc_us-gaap_ShareBasedCompensation_ca17775b-ab6f-4d68-935f-593a662867cf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_75e128e0-9ff4-4685-b4e3-698cec49a8bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c99018e3-0a67-4b6c-8404-d59adf9a8348" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_75e128e0-9ff4-4685-b4e3-698cec49a8bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_f946009b-b78e-4f2c-b52a-fafb1fe3d63b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c99018e3-0a67-4b6c-8404-d59adf9a8348" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_f946009b-b78e-4f2c-b52a-fafb1fe3d63b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1d581826-34a1-4b7a-acbb-ac513ced39a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c99018e3-0a67-4b6c-8404-d59adf9a8348" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1d581826-34a1-4b7a-acbb-ac513ced39a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_725e5156-1195-4b9e-983a-b19d571d1c22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c99018e3-0a67-4b6c-8404-d59adf9a8348" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_725e5156-1195-4b9e-983a-b19d571d1c22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_58ec2ffe-537c-42d5-921f-89d9f7b884f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c99018e3-0a67-4b6c-8404-d59adf9a8348" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_58ec2ffe-537c-42d5-921f-89d9f7b884f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_959192e7-6417-45c8-b907-35b67565fdb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c99018e3-0a67-4b6c-8404-d59adf9a8348" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_959192e7-6417-45c8-b907-35b67565fdb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_432d3cc9-69ec-4e2f-984a-a6b27111c28a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c99018e3-0a67-4b6c-8404-d59adf9a8348" xlink:to="loc_us-gaap_NetIncomeLoss_432d3cc9-69ec-4e2f-984a-a6b27111c28a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4d1468ed-e649-4351-981e-e5184c9e2a34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c99018e3-0a67-4b6c-8404-d59adf9a8348" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_4d1468ed-e649-4351-981e-e5184c9e2a34" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_55201a58-627d-4379-9158-a94ee1517bc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c99018e3-0a67-4b6c-8404-d59adf9a8348" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_55201a58-627d-4379-9158-a94ee1517bc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_864f8f8b-68f4-4e07-8a79-c5322ccb7d5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_c99018e3-0a67-4b6c-8404-d59adf9a8348" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_864f8f8b-68f4-4e07-8a79-c5322ccb7d5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_aaf34c17-b228-423c-85e3-ce78f1ca17f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_125039d1-0a07-45b8-b888-9b705e228ec2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_aaf34c17-b228-423c-85e3-ce78f1ca17f4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_125039d1-0a07-45b8-b888-9b705e228ec2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dc5775aa-e0ce-41f3-8a44-355d3920923a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_aaf34c17-b228-423c-85e3-ce78f1ca17f4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_dc5775aa-e0ce-41f3-8a44-355d3920923a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a5a8cdf2-81e5-4afb-889a-e6cdd44f0bd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_aaf34c17-b228-423c-85e3-ce78f1ca17f4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a5a8cdf2-81e5-4afb-889a-e6cdd44f0bd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3696527d-88e3-4853-a111-1ddfd7ef1247" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAcquiredFromAcquisition_fcd5b5f2-82ed-46b7-94ee-086a6ce643bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAcquiredFromAcquisition"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3696527d-88e3-4853-a111-1ddfd7ef1247" xlink:to="loc_us-gaap_CashAcquiredFromAcquisition_fcd5b5f2-82ed-46b7-94ee-086a6ce643bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7dffb742-db87-46ab-804d-f3e16412de16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3696527d-88e3-4853-a111-1ddfd7ef1247" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_7dffb742-db87-46ab-804d-f3e16412de16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_de2d1f74-77cb-4c92-b29b-8d00db205791" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3696527d-88e3-4853-a111-1ddfd7ef1247" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_de2d1f74-77cb-4c92-b29b-8d00db205791" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="flks-20201231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/ORGANIZATIONANDOPERATIONS" xlink:type="simple" xlink:href="flks-20201231.xsd#ORGANIZATIONANDOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/ORGANIZATIONANDOPERATIONS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="flks-20201231.xsd#BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="flks-20201231.xsd#BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="simple" xlink:href="flks-20201231.xsd#BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/BASISOFPRESENTATIONANDSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSAL" xlink:type="simple" xlink:href="flks-20201231.xsd#REVERSEACQUISITIONANDDISPOSAL"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSAL" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALTables" xlink:type="simple" xlink:href="flks-20201231.xsd#REVERSEACQUISITIONANDDISPOSALTables"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALNarrativeDetails" xlink:type="simple" xlink:href="flks-20201231.xsd#REVERSEACQUISITIONANDDISPOSALNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALSummaryofPurchaseConsiderationDetails" xlink:type="simple" xlink:href="flks-20201231.xsd#REVERSEACQUISITIONANDDISPOSALSummaryofPurchaseConsiderationDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALSummaryofPurchaseConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_fc1e8fc7-b9b8-435d-97cc-536837a20c23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_e00290d7-02ab-4c6f-b9a1-1810f3a2a565" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_fc1e8fc7-b9b8-435d-97cc-536837a20c23" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_e00290d7-02ab-4c6f-b9a1-1810f3a2a565" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_flks_BusinessCombinationConsiderationTransferredFairValueOfRightsToWarrants_749a0691-a2f7-45cb-8e30-2d52e9149541" xlink:href="flks-20201231.xsd#flks_BusinessCombinationConsiderationTransferredFairValueOfRightsToWarrants"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_fc1e8fc7-b9b8-435d-97cc-536837a20c23" xlink:to="loc_flks_BusinessCombinationConsiderationTransferredFairValueOfRightsToWarrants_749a0691-a2f7-45cb-8e30-2d52e9149541" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_flks_BusinessCombinationConsiderationTransferredFairValueOfOutstandingOptions_a6a26f79-2f5d-48f9-9896-281ab2dea727" xlink:href="flks-20201231.xsd#flks_BusinessCombinationConsiderationTransferredFairValueOfOutstandingOptions"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1_fc1e8fc7-b9b8-435d-97cc-536837a20c23" xlink:to="loc_flks_BusinessCombinationConsiderationTransferredFairValueOfOutstandingOptions_a6a26f79-2f5d-48f9-9896-281ab2dea727" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="flks-20201231.xsd#REVERSEACQUISITIONANDDISPOSALScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALScheduleofRecognizedIdentifiedAssetsAcquiredandLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_df7ca01b-0349-4234-85d3-c0096536a566" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_9ce50f02-0162-4e31-8a26-6d7bc60d9db9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_df7ca01b-0349-4234-85d3-c0096536a566" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_9ce50f02-0162-4e31-8a26-6d7bc60d9db9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f07b8f06-d784-4604-bb78-c58ab074bae7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_a4225c33-4048-441c-a5ce-f16aa744ff7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f07b8f06-d784-4604-bb78-c58ab074bae7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_a4225c33-4048-441c-a5ce-f16aa744ff7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_516f5f81-05dc-4597-be47-b30cbc2f76bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f07b8f06-d784-4604-bb78-c58ab074bae7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_516f5f81-05dc-4597-be47-b30cbc2f76bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_509abde9-5897-41cb-9833-05cdea8b5631" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f07b8f06-d784-4604-bb78-c58ab074bae7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_509abde9-5897-41cb-9833-05cdea8b5631" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_flks_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwillAndIntangibleAssets_3ceb0a8d-b874-4f67-ab36-19ac3e9eb0d5" xlink:href="flks-20201231.xsd#flks_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f07b8f06-d784-4604-bb78-c58ab074bae7" xlink:to="loc_flks_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedGoodwillAndIntangibleAssets_3ceb0a8d-b874-4f67-ab36-19ac3e9eb0d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6c099eaa-3518-486a-810a-7f572fad2761" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_f07b8f06-d784-4604-bb78-c58ab074bae7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_6c099eaa-3518-486a-810a-7f572fad2761" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_5ce74fd3-adab-43c8-a9d7-5bae5a81d0b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e4b5b1de-99d3-4bdf-b21c-cfba25216f89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_5ce74fd3-adab-43c8-a9d7-5bae5a81d0b9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_e4b5b1de-99d3-4bdf-b21c-cfba25216f89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_b12d393f-8ea0-40ce-b53c-3ccf068974cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_5ce74fd3-adab-43c8-a9d7-5bae5a81d0b9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_b12d393f-8ea0-40ce-b53c-3ccf068974cb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALSummaryofSaleofBusinessDetails" xlink:type="simple" xlink:href="flks-20201231.xsd#REVERSEACQUISITIONANDDISPOSALSummaryofSaleofBusinessDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALSummaryofSaleofBusinessDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_aaeb8b82-020f-426d-9b0a-0448092ddae2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:loc xlink:type="locator" xlink:label="loc_flks_DisposalGroupNotDiscontinuedOperationCarryingValueOfGoodwillAndIntangibleAssetsSold_85fae444-d8c6-464a-a6b8-6a150ecaa03a" xlink:href="flks-20201231.xsd#flks_DisposalGroupNotDiscontinuedOperationCarryingValueOfGoodwillAndIntangibleAssetsSold"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_aaeb8b82-020f-426d-9b0a-0448092ddae2" xlink:to="loc_flks_DisposalGroupNotDiscontinuedOperationCarryingValueOfGoodwillAndIntangibleAssetsSold_85fae444-d8c6-464a-a6b8-6a150ecaa03a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_flks_DisposalGroupNotDiscontinuedOperationLiabilitiesTransferredUponSale_fd5893c1-094d-4abf-975f-a53fcb5d740e" xlink:href="flks-20201231.xsd#flks_DisposalGroupNotDiscontinuedOperationLiabilitiesTransferredUponSale"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_aaeb8b82-020f-426d-9b0a-0448092ddae2" xlink:to="loc_flks_DisposalGroupNotDiscontinuedOperationLiabilitiesTransferredUponSale_fd5893c1-094d-4abf-975f-a53fcb5d740e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_813df426-6629-45f8-b00d-f9e057daaf49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_aaeb8b82-020f-426d-9b0a-0448092ddae2" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_813df426-6629-45f8-b00d-f9e057daaf49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_flks_DisposalGroupNotDiscontinuedOperationCarryingValueOfTangibleAssetsSold_56d3a4ee-a5b5-424a-9a02-6acf460ab844" xlink:href="flks-20201231.xsd#flks_DisposalGroupNotDiscontinuedOperationCarryingValueOfTangibleAssetsSold"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_aaeb8b82-020f-426d-9b0a-0448092ddae2" xlink:to="loc_flks_DisposalGroupNotDiscontinuedOperationCarryingValueOfTangibleAssetsSold_56d3a4ee-a5b5-424a-9a02-6acf460ab844" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_flks_DisposalGroupNotDiscontinuedOperationCostsIncurredRelatedToSale_2f8192fb-80b6-4428-b99f-4c375862b7eb" xlink:href="flks-20201231.xsd#flks_DisposalGroupNotDiscontinuedOperationCostsIncurredRelatedToSale"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_aaeb8b82-020f-426d-9b0a-0448092ddae2" xlink:to="loc_flks_DisposalGroupNotDiscontinuedOperationCostsIncurredRelatedToSale_2f8192fb-80b6-4428-b99f-4c375862b7eb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALScheduleofUnauditedProFormaResultsDetails" xlink:type="simple" xlink:href="flks-20201231.xsd#REVERSEACQUISITIONANDDISPOSALScheduleofUnauditedProFormaResultsDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/REVERSEACQUISITIONANDDISPOSALScheduleofUnauditedProFormaResultsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETS" xlink:type="simple" xlink:href="flks-20201231.xsd#PREPAIDEXPENSESANDOTHERCURRENTASSETS"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETSTables" xlink:type="simple" xlink:href="flks-20201231.xsd#PREPAIDEXPENSESANDOTHERCURRENTASSETSTables"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETSScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="flks-20201231.xsd#PREPAIDEXPENSESANDOTHERCURRENTASSETSScheduleofPrepaidExpensesandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETSScheduleofPrepaidExpensesandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8f190b4e-346a-4259-8051-43e98c449519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_72267dca-5cbd-4d92-9c3c-42df40f8400f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8f190b4e-346a-4259-8051-43e98c449519" xlink:to="loc_us-gaap_OtherAssetsCurrent_72267dca-5cbd-4d92-9c3c-42df40f8400f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_flks_PrepaidClinicalTrialExpense_8100c148-0451-4cdb-8735-943ed620520e" xlink:href="flks-20201231.xsd#flks_PrepaidClinicalTrialExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8f190b4e-346a-4259-8051-43e98c449519" xlink:to="loc_flks_PrepaidClinicalTrialExpense_8100c148-0451-4cdb-8735-943ed620520e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidInsurance_7d367d4b-c83e-48bf-ba6c-2d2a94770b8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidInsurance"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_8f190b4e-346a-4259-8051-43e98c449519" xlink:to="loc_us-gaap_PrepaidInsurance_7d367d4b-c83e-48bf-ba6c-2d2a94770b8f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETSNarrativeDetails" xlink:type="simple" xlink:href="flks-20201231.xsd#PREPAIDEXPENSESANDOTHERCURRENTASSETSNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/PREPAIDEXPENSESANDOTHERCURRENTASSETSNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="flks-20201231.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="flks-20201231.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/FAIRVALUEOFFINANCIALINSTRUMENTS" xlink:type="simple" xlink:href="flks-20201231.xsd#FAIRVALUEOFFINANCIALINSTRUMENTS"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/FAIRVALUEOFFINANCIALINSTRUMENTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/FAIRVALUEOFFINANCIALINSTRUMENTSTables" xlink:type="simple" xlink:href="flks-20201231.xsd#FAIRVALUEOFFINANCIALINSTRUMENTSTables"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/FAIRVALUEOFFINANCIALINSTRUMENTSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/FAIRVALUEOFFINANCIALINSTRUMENTSSummaryofChangesinFairValueofLevel3LiabilitiesDetails" xlink:type="simple" xlink:href="flks-20201231.xsd#FAIRVALUEOFFINANCIALINSTRUMENTSSummaryofChangesinFairValueofLevel3LiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/FAIRVALUEOFFINANCIALINSTRUMENTSSummaryofChangesinFairValueofLevel3LiabilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="flks-20201231.xsd#STOCKHOLDERSEQUITY"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITYTables" xlink:type="simple" xlink:href="flks-20201231.xsd#STOCKHOLDERSEQUITYTables"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITYTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="flks-20201231.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITYScheduleofVariablesusedinBlackScholesModelDetails" xlink:type="simple" xlink:href="flks-20201231.xsd#STOCKHOLDERSEQUITYScheduleofVariablesusedinBlackScholesModelDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/STOCKHOLDERSEQUITYScheduleofVariablesusedinBlackScholesModelDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATION" xlink:type="simple" xlink:href="flks-20201231.xsd#EQUITYBASEDCOMPENSATION"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATION" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="flks-20201231.xsd#EQUITYBASEDCOMPENSATIONTables"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="flks-20201231.xsd#EQUITYBASEDCOMPENSATIONNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONScheduleofFairValueAssumptionsDetails" xlink:type="simple" xlink:href="flks-20201231.xsd#EQUITYBASEDCOMPENSATIONScheduleofFairValueAssumptionsDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONScheduleofFairValueAssumptionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONSummaryofstockoptionactivityDetails" xlink:type="simple" xlink:href="flks-20201231.xsd#EQUITYBASEDCOMPENSATIONSummaryofstockoptionactivityDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/EQUITYBASEDCOMPENSATIONSummaryofstockoptionactivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/INCOMETAX" xlink:type="simple" xlink:href="flks-20201231.xsd#INCOMETAX"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/INCOMETAX" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/INCOMETAXTables" xlink:type="simple" xlink:href="flks-20201231.xsd#INCOMETAXTables"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/INCOMETAXTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/INCOMETAXNarrativeDetails" xlink:type="simple" xlink:href="flks-20201231.xsd#INCOMETAXNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/INCOMETAXNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/INCOMETAXScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="flks-20201231.xsd#INCOMETAXScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/INCOMETAXScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_3ec5d6b3-a4c9-405b-98a4-b28f5814cef5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_bb5cae23-5b3f-4661-a833-3ac96ba3efc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_3ec5d6b3-a4c9-405b-98a4-b28f5814cef5" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_bb5cae23-5b3f-4661-a833-3ac96ba3efc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_f8c86ed8-6885-4180-ad60-c249581749e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_3ec5d6b3-a4c9-405b-98a4-b28f5814cef5" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_f8c86ed8-6885-4180-ad60-c249581749e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_45396781-a9e5-4713-a22d-7401d7ac3acc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_8e2471dc-4635-4fd4-bd15-3a355b218a2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_45396781-a9e5-4713-a22d-7401d7ac3acc" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_8e2471dc-4635-4fd4-bd15-3a355b218a2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_27f95679-a4d1-4c75-8cc6-2a25ad7095a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_45396781-a9e5-4713-a22d-7401d7ac3acc" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_27f95679-a4d1-4c75-8cc6-2a25ad7095a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_7413f976-4139-4e16-a6e2-517ab98f717a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_45396781-a9e5-4713-a22d-7401d7ac3acc" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_7413f976-4139-4e16-a6e2-517ab98f717a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_d0d09cca-c1f2-4f3f-a9a5-fe6d34e99343" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_45396781-a9e5-4713-a22d-7401d7ac3acc" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_d0d09cca-c1f2-4f3f-a9a5-fe6d34e99343" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_8a3f5976-aef4-4550-a1a4-8d993720865d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_45396781-a9e5-4713-a22d-7401d7ac3acc" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_8a3f5976-aef4-4550-a1a4-8d993720865d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts_69c66337-5495-423c-af1a-4c47fc8e094f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_45396781-a9e5-4713-a22d-7401d7ac3acc" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts_69c66337-5495-423c-af1a-4c47fc8e094f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/INCOMETAXScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="flks-20201231.xsd#INCOMETAXScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/INCOMETAXScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_98e90c73-7b07-4b87-9a61-42a1224f0554" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_9996f993-5ced-469d-ad96-6c98d2df7195" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_98e90c73-7b07-4b87-9a61-42a1224f0554" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_9996f993-5ced-469d-ad96-6c98d2df7195" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_2f56a5cf-4db1-4242-8664-5409bba9055e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_98e90c73-7b07-4b87-9a61-42a1224f0554" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_2f56a5cf-4db1-4242-8664-5409bba9055e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_a478a739-6584-4b70-946f-81064b9d7014" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_98e90c73-7b07-4b87-9a61-42a1224f0554" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_a478a739-6584-4b70-946f-81064b9d7014" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_efe85c99-95b5-405c-9aed-603ad7f7c01b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_98e90c73-7b07-4b87-9a61-42a1224f0554" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_efe85c99-95b5-405c-9aed-603ad7f7c01b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_b45b9afa-7a4d-4ab5-8f03-957a01b7935f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_98e90c73-7b07-4b87-9a61-42a1224f0554" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_b45b9afa-7a4d-4ab5-8f03-957a01b7935f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/PAYROLLPROTECTIONPROGRAM" xlink:type="simple" xlink:href="flks-20201231.xsd#PAYROLLPROTECTIONPROGRAM"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/PAYROLLPROTECTIONPROGRAM" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/PAYROLLPROTECTIONPROGRAMDetails" xlink:type="simple" xlink:href="flks-20201231.xsd#PAYROLLPROTECTIONPROGRAMDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/PAYROLLPROTECTIONPROGRAMDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/SUBSEQUENTEVENTS" xlink:type="simple" xlink:href="flks-20201231.xsd#SUBSEQUENTEVENTS"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/SUBSEQUENTEVENTS" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.flex-pharma.com/role/SUBSEQUENTEVENTSDetails" xlink:type="simple" xlink:href="flks-20201231.xsd#SUBSEQUENTEVENTSDetails"/>
  <link:calculationLink xlink:role="http://www.flex-pharma.com/role/SUBSEQUENTEVENTSDetails" xlink:type="extended"/>
</link:linkbase>
